Information from US FDA——Impact of Severe Weather Conditions on Biological Products & FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease

http://www.fda.gov

Journal of Chinese Pharmaceutical Sciences . 2018, (2): 138 -140 .